In addition to the software, MMS has the technical leadership in the disclosure arena. Joe Archer leads the disclosure teams at MMS and brings with him a depth of technical experience and regulatory feedback on the process. Archer managed clinical trial disclosure operations in the past for large pharmaceutical companies such as GlaxoSmithKline and Pfizer.
"We have the staff expertise, proven process, and TrialAssure™
About MMS Holdings Inc.
MMS Holdings Inc. is a clinical research organization that focuses on regulatory submission support for the pharmaceutical, biotech and medical device industries. Our strong industry experience and scientific approach to drug development makes us a valuable partner in creating compelling submissions that meet rigorous regulatory standards. Our clients span from top 10 pharma to virtual biotech's, and we support each one with the same standard of excellence. Our core service areas include Data Management, Biostatistics, Clinical Programming, Medical and Regulatory Writing, Pharmacovigilance, Clinical Trial Disclosure and Oncology Data Abstraction. Commitment to quality deliverables sets MMS apart from traditional service providers. MMS is the only CRO to be ISO 9001 certified for all services since inception and we maintain detailed quality metrics for every project. For more information visit: http://www.mmsholdings.com